Effect of Dietary Methylseleninic Acid and Se-Methylselenocysteine on Carcinogen-Induced, Androgen-Promoted Prostate Carcinogenesis in Rats

References

• Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, Stattin P, Van Poppel H, La Vecchia C. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877–92. doi: 10.1016/j.euo.2021.09.006.
   PubMed Web of Science ®Google Scholar
• Bosland MC. Is there a future for chemoprevention of prostate cancer? Cancer Prev Res (Phila). 2016;9(8):642–7. doi: 10.1158/1940-6207.CAPR-16-0088.
   PubMed Web of Science ®Google Scholar
• Sandhu GS, Nepple KG, Tanagho YS, Andriole GL. Prostate cancer chemoprevention. Semin Oncol. 2013;40(3):276–85. doi: 10.1053/j.seminoncol.2013.04.003.
   PubMed Web of Science ®Google Scholar
• Parnes HL, House MG, Tangrea JA. Prostate cancer prevention: strategies for agent development. Curr Opin Oncol. 2013;25(3):242–51. doi: 10.1097/CCO.0b013e32835fc8d4.
   PubMed Web of Science ®Google Scholar
• Clark LC, Dalkin B, Krongrad A, Combs GF, Jr, Turnbull BW, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. BJU Int. 1998;81(5):730–4. doi:10.1046/j.1464-410x.1998.00630.x
   Google Scholar
• Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF, Jr, Slate EH, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev. 2002;11(7):630–9.
   PubMed Web of Science ®Google Scholar
• Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA. 2009;301(1):39–51. doi: 10.1001/jama.2008.864.
   PubMed Web of Science ®Google Scholar
• Marshall JR, Tangen CM, Sakr WA, Wood DP, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF, et al. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila). 2011;4(11):1761–9. doi:10.1158/1940-6207.CAPR-10-0343
   PubMed Web of Science ®Google Scholar
• Algotar AM, Stratton MS, Ahmann FR, Ranger-Moore J, Nagle RB, Thompson PA, Slate E, Hsu CH, Dalkin BL, Sindhwani P, et al. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate. 2013;73(3):328–35. doi: 10.1002/pros.22573.
   PubMed Web of Science ®Google Scholar
• Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, et al. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst. 2014;106(3) djt456. doi:10.1093/jnci/djt456
   Google Scholar
• Nadiminty N, Gao AC. Mechanisms of selenium chemoprevention and therapy in prostate cancer. Mol Nutr Food Res. 2008;52(11):1247–60. doi: 10.1002/mnfr.200700369.
   PubMed Web of Science ®Google Scholar
• Venkateswaran V, Klotz LH. Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nat Rev Urol. 2010;7(8):442–53. doi: 10.1038/nrurol.2010.102.
   PubMed Web of Science ®Google Scholar
• McCormick DL, Rao KVN, Johnson WD, Bosland MC, Lubet RA, Steele VE. Null activity of selenium and vitamin E as cancer chemopreventive agents in the rat prostate. Cancer Prev Res (Phila). 2010;3(3):381–92. doi: 10.1158/1940-6207.CAPR-09-0176.
   PubMed Web of Science ®Google Scholar
• Bosland MC, McCormick DL. The MNU plus testosterone rat model of prostate carcinogenesis. Toxcol Pathol. 2022. doi:10.1177/01926233221096345
   PubMed Web of Science ®Google Scholar
• Özten N, Schlicht M, Diamond AM, Bosland MC. L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL rats. Nutr Cancer. 2014;66(5):825–34. doi:10.1080/01635581.2014.904907
   PubMed Web of Science ®Google Scholar
• Wang L, Bonorden MJ, Li G-x, Lee H-J, Hu H, Zhang Y, Liao JD, Cleary MP, Lü J. Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prev Res (Phila). 2009;2(5):484–95. doi:10.1158/1940-6207.CAPR-08-0173
   PubMed Web of Science ®Google Scholar
• Li G-x, Lee H-J, Wang Z, Hu H, Liao JD, Watts JC, Combs GF, Lü J. Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis. 2008;29(5):1005–12. doi: 10.1093/carcin/bgn007.
   PubMed Web of Science ®Google Scholar
• Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Prostate. 2006;66(10):1070–5. doi:10.1002/pros.20329
   PubMed Web of Science ®Google Scholar
• Wang L, Guo X, Wang J, Jiang C, Bosland MC, Lü J, Deng Y. Methylseleninic acid superactivates p53-senescence cancer progression barrier in prostate lesions of Pten-knockout mouse. Cancer Prev Res (Phila). 2016;9(1):35–42. doi: 10.1158/1940-6207.CAPR-15-0236.
   PubMed Web of Science ®Google Scholar
• Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr. 1998;128(11):1845–54. doi: 10.1093/jn/128.11.1845.
   PubMed Web of Science ®Google Scholar
• Ip C, Thompson HJ, Zhu Z, Ganther HE. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res. 2000;60(11):2882–6.
   PubMed Web of Science ®Google Scholar
• Lü J, Zhang J, Jiang C, Deng Y, Özten N, Bosland MC. Cancer chemoprevention research with selenium in the post-SELECT era: promises and challenges. Nutr Cancer. 2016;68(1):1–17. doi: 10.1080/01635581.2016.1105267.
   PubMed Web of Science ®Google Scholar
• Cho SD, Jiang C, Malewicz B, Dong Y, Young CYF, Kang K-S, Lee Y-S, Ip C, Lü J. Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. Mol Cancer Ther. 2004;3(5):605–11. doi: 10.1158/1535-7163.605.3.5. PMID: 15141018.
   PubMed Web of Science ®Google Scholar
• Hu W, Ma Y, Zhao C, Yin S, Hu H. Methylseleninic acid overcomes programmed death-ligand 1-mediated resistance of prostate cancer and lung cancer. Mol Carcinog. 2021;60(11):746–57. doi: 10.1002/mc.23340.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang L, Anderson LB, Witthuhn B, Xu Y, Lü J. Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model. Cancer Prev Res (Phila). 2010;3(8):994–1006. doi: 10.1158/1940-6207.CAPR-09-0261.
   PubMed Web of Science ®Google Scholar
• Bosland MC. Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology. 2014;155(12):4629–33. doi: 10.1210/en.2014-1688.
   PubMed Web of Science ®Google Scholar
• Yan L, DeMars LC. Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice. Int J Cancer. 2012;131(6):1260–6. doi:10.1002/ijc.27355
   PubMed Web of Science ®Google Scholar
• Ali MA, Kravitz AV. Challenges in quantifying food intake in rodents. Brain Res. 2018;1693(Pt B):188–91. doi: 10.1016/j.brainres.2018.02.040.
   PubMed Web of Science ®Google Scholar
• McCormick DL, Rao KV, Dooley L, Steele VE, Lubet RA, et al. Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats. Cancer Res. 1998;58(15):3282–8.
   PubMed Web of Science ®Google Scholar
• Johnson WD, Morrissey RL, Kapetanovic I, Crowell JA, McCormick DL. Subchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer prevention. Food Chem Toxicol. 2008;46(3):1068–78. doi:10.1016/j.fct.2007.11.001
   PubMed Web of Science ®Google Scholar
• El-Bayoumy K, Sinha R. Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res. 2004;551(1-2):181–97. doi: 10.1016/j.mrfmmm.2004.02.023.
   PubMed Web of Science ®Google Scholar
• Hu H, Li G-X, Wang L, Watts J, Combs GF, Lü J. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and surviving. Clin Cancer Res. 2008;14(4):1150–8. doi:10.1158/1078-0432.CCR-07-4037.
   PubMed Web of Science ®Google Scholar
• Waters DJ, Chiang EC. Five threads: how U-shaped thinking weaves together dogs, men, selenium, and prostate cancer risk. Free Radic Biol Med. 2018;127:36–45. doi: 10.1016/j.freeradbiomed.2017.12.039.
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. Faseb J. 2008;22(3):659–61. doi: 10.1096/fj.07-9574LSF.
   PubMed Web of Science ®Google Scholar
• Marshall JR, Ip C, Romano K, Fetterly G, Fakih M, Jovanovic B, Perloff M, Crowell J, Davis W, French-Christy R, et al. Methyl selenocysteine: single-dose pharmacokinetics in men. Cancer Prev Res (Phila). 2011;4(11):1938–44. doi: 10.1158/1940-6207.CAPR-10-0259.
   PubMed Web of Science ®Google Scholar